ENOV vs HNGE
ENOV: A medical technology company providing a comprehensive continuum of orthopedic care, from injury prevention and rehabilitation products to surgical reconstructive implants. HNGE: Hinge Health is an AI-driven digital MSK care platform that automates personalized pain treatment and physical therapy through motion-tracking technology and wearable devices, scaling care to millions while reducing surgical need and employer costs.
Side-by-side fundamentals
| Metric | ENOV | HNGE | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $28.25 | $75.11 | |
| Market cap as of 2026-07-31 | $1.7B | $5.7B | |
| PEG as of 2026-07-31 | -0.04 | n/a | |
| Net margin as of 2026-07-31 | -49.9% | -79.0% | ENOV higher |
| Gross margin as of 2026-07-31 | +60.4% | +80.8% | HNGE higher |
| Operating margin as of 2026-07-31 | -47.1% | -81.6% | ENOV higher |
| ROE as of 2026-07-31 | -60.1% | -138.7% | ENOV higher |
| ROA as of 2026-07-31 | -26.6% | -69.5% | ENOV higher |
| Debt / equity as of 2026-07-31 | 0.90 | 0.00 | HNGE lower |
| Revenue growth (YoY) as of 2026-07-31 | +6.0% | +47.2% | HNGE higher |
| Revenue CAGR (3y) SEC XBRL | +12.9% | +41.7% | HNGE higher |
| Beta as of 2026-07-31 | 1.36 | 1.63 | |
| 1-year return as of 2026-07-27 close | +2.6% | +64.1% | HNGE higher |
Fundamentals: market data, as of 2026-07-31. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.